918博天堂(中华区)官方网站

RESEARCH AND DEVELOPMENT

A Randomized,Double-Blind, Single-Dose Study Comparing the Biosimilarity of HOT-1010 with Bevacizumab (Avastin®) in Chinese Healthy Male Subjects

2021-06-17 1142

A Randomized,Double-Blind, Single-Dose Study Comparing the Biosimilarity of HOT-1010 with Bevacizumab  (Avastin®) in Chinese Healthy Male Subjects

 

Original Research Article:

Frontiers in Pharmacology

http://doi: 10.3389/fphar.2021.694375


友情链接: